Xiyue Yang

528 total citations
23 papers, 380 citations indexed

About

Xiyue Yang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiyue Yang has authored 23 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiyue Yang's work include Lung Cancer Research Studies (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Xiyue Yang is often cited by papers focused on Lung Cancer Research Studies (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Xiyue Yang collaborates with scholars based in China, Bangladesh and United States. Xiyue Yang's co-authors include Jie Chao, Zewei Zhou, Rong Jiang, Yusi Cheng, Honghong Yao, Huifang Guo, Ying‐Ming Zhang, Jiang Wang, Shencun Fang and Xiaobo Du and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and The FASEB Journal.

In The Last Decade

Xiyue Yang

21 papers receiving 377 citations

Peers

Xiyue Yang
Feilong Yang China
Marc Gigante France
Jianyi Zheng China
Qiuyang Zhao China
Shifang Sun China
Chuanliang Xu China
Jiyue Wu China
Yuming Jia China
Álvaro Fernández‐Pardo Spain
Feilong Yang China
Xiyue Yang
Citations per year, relative to Xiyue Yang Xiyue Yang (= 1×) peers Feilong Yang

Countries citing papers authored by Xiyue Yang

Since Specialization
Citations

This map shows the geographic impact of Xiyue Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiyue Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiyue Yang more than expected).

Fields of papers citing papers by Xiyue Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiyue Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiyue Yang. The network helps show where Xiyue Yang may publish in the future.

Co-authorship network of co-authors of Xiyue Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiyue Yang. A scholar is included among the top collaborators of Xiyue Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiyue Yang. Xiyue Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Xiyue, et al.. (2025). Discovery of Artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer. European Journal of Medicinal Chemistry. 293. 117710–117710. 3 indexed citations
3.
Deng, Jianping, et al.. (2025). Advances in radiotherapy enhancing the efficacy of immune checkpoint inhibitors in malignant. Frontiers in Oncology. 15. 1611036–1611036.
4.
5.
Yang, Xiyue, et al.. (2024). Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with Clusterin/SREBP1/FASN signaling pathway. Korean Journal of Physiology and Pharmacology. 28(3). 219–227. 2 indexed citations
6.
Yang, Xiyue, Binwei Lin, Jie Li, et al.. (2024). High-intensity focused ultrasound ablation combined with immunotherapy for treating liver metastases: A prospective non-randomized trial. PLoS ONE. 19(7). e0306595–e0306595. 7 indexed citations
7.
Yang, Wenjing, Hao Ma, Qiaoyu Wang, et al.. (2024). Fluoride-induced hypertension by regulating RhoA/ROCK pathway and phenotypic transformation of vascular smooth muscle cells: In vitro and in vivo evidence. Ecotoxicology and Environmental Safety. 281. 116681–116681. 2 indexed citations
8.
Yang, Xiyue, et al.. (2024). Optimization Design Methods for Thermal Environment Problems in Chinese University Teaching Buildings at Various Periods. Sustainability. 16(15). 6547–6547. 1 indexed citations
9.
Yang, Xiyue, et al.. (2023). A novel Nlrp3 knock-in mouse model with hyperactive inflammasome in development of lethal inflammation. Clinical & Experimental Immunology. 215(2). 202–214. 2 indexed citations
10.
Qi, Ke, Minjie Zhou, Gang Xie, et al.. (2023). Combined Morphological and Spectroscopic Diagnostic of HER2 Expression in Breast Cancer Tissues Based on Label-Free Surface-Enhanced Raman Scattering. Analytical Chemistry. 95(5). 3019–3027. 15 indexed citations
11.
Liu, Jihui, Xiyue Yang, Xin Mao, et al.. (2023). Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models. Frontiers in Oncology. 13. 1089365–1089365. 1 indexed citations
12.
Yang, Xiyue, et al.. (2022). Synthesis and Antitumor Activities of Novel Mitochondria-Targeted Dihydroartemisinin Ether Derivatives. ACS Omega. 7(43). 38832–38846. 3 indexed citations
13.
Zhang, Yu, Jie Li, Zhike Li, et al.. (2021). Impact of Coronavirus Disease 2019 on Clinical Characteristics in Patients With Lung Cancer: A Large Single-Centre Retrospective Study. Frontiers in Oncology. 11. 693002–693002. 8 indexed citations
14.
15.
Li, Jie, Zhongzheng Xiang, Huan Du, et al.. (2020). Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer. Radiotherapy and Oncology. 154. 201–206. 27 indexed citations
16.
Lin, Binwei, Dan Huang, Xiyue Yang, et al.. (2020). Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy. Cancer Imaging. 20(1). 29–29. 12 indexed citations
17.
Yang, Xiyue, et al.. (2019). Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial. Asian Pacific Journal of Cancer Prevention. 20(12). 3849–3853. 5 indexed citations
18.
Li, Jie, Zhenhua Zhao, Tangzhi Dai, et al.. (2019). Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy. Medicine. 98(26). e16176–e16176. 8 indexed citations
19.
Dai, Xiaoniu, Zewei Zhou, Rong Jiang, et al.. (2017). circHIPK2-mediated σ-1R promotes endoplasmic reticulum stress in human pulmonary fibroblasts exposed to silica. Cell Death and Disease. 8(12). 3212–3212. 42 indexed citations
20.
Zhou, Zewei, Rong Jiang, Xiyue Yang, et al.. (2017). circRNA Mediates Silica-Induced Macrophage Activation Via HECTD1/ZC3H12A-Dependent Ubiquitination. Theranostics. 8(2). 575–592. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feilong Yang Breakdown of academic impact, for papers by Marc Gigante Breakdown of academic impact, for papers by Jianyi Zheng Breakdown of academic impact, for papers by Qiuyang Zhao Breakdown of academic impact, for papers by Shifang Sun Breakdown of academic impact, for papers by Chuanliang Xu Breakdown of academic impact, for papers by Jiyue Wu Breakdown of academic impact, for papers by Yuming Jia Breakdown of academic impact, for papers by Álvaro Fernández‐Pardo
Rankless by CCL
2026